Ceera Investments’s AbbVie ABBV Stock Holding History

Ceera Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Sell	4,743 -124	-3%	-$26.7K	0.51%	50
2026 Q1	$1.06M	Sell	4,867 -757	-13%	-$168K	0.46%	49
2025 Q4	$1.29M	Sell	5,624 -3,757	-40%	-$856K	0.5%	41
2025 Q3	$2.17M	Sell	9,381 -25	-0.3%	-$5.09K	0.68%	40
2025 Q2	$1.75M	Sell	9,406 -15	-0.2%	-$2.79K	0.53%	42
2025 Q1	$1.97M	Sell	9,421 -50	-0.5%	-$9.72K	0.68%	38
2024 Q4	$1.68M	Sell	9,471 -160	-2%	-$29.4K	0.58%	41
2024 Q3	$1.9M	Buy	9,631 +469	+5%	+$87.5K	0.72%	38
2024 Q2	$1.57M	Buy	9,162 +3	+0%	+$497	0.66%	38
2024 Q1	$1.67M	Hold	9,159	–	–	0.73%	35
2023 Q4	$1.42M	Sell	9,159 -45	-0.5%	-$6.56K	0.67%	33
2023 Q3	$1.37M	Hold	9,204	–	–	0.75%	40
2023 Q2	$1.24M	Hold	9,204	–	–	0.72%	37
2023 Q1	$1.47M	Hold	9,204	–	–	0.94%	33
2022 Q4	$1.49M	Sell	9,204 -95	-1%	-$14.6K	0.94%	40
2022 Q3	$1.25M	Hold	9,299	–	–	0.83%	46
2022 Q2	$1.42M	Sell	9,299 -25	-0.3%	-$3.82K	0.81%	40
2022 Q1	$1.51M	Sell	9,324 -945	-9%	-$137K	0.75%	37
2021 Q4	$1.39M	Sell	10,269 -255	-2%	-$30.1K	0.72%	37
2021 Q3	$1.14M	Buy	10,524 +5,430	+107%	+$620K	0.62%	41
2021 Q2	$574K	Buy	5,094 +1,392	+38%	+$157K	0.44%	40
2021 Q1	$401K	Buy	+3,702	New	+$396K	0.33%	42

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ceera Investments's ABBV Position: Q2 2026 in Review

Ceera Investments reduced its AbbVie (ABBV) stake by 2.5% in Q2 2026, selling an estimated $26.7K and leaving 4,743 shares worth $1.19M. The position accounts for 0.51% of the portfolio, ranked #50.

Ceera Investments first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.17M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ceera Investments held 4,743 shares of AbbVie worth $1.19M as of Q2 2026.
Ceera Investments sold 124 AbbVie shares in Q2 2026, an estimated $26.7K.
AbbVie made up 0.51% of Ceera Investments's portfolio in Q2 2026, its #50 holding.
Ceera Investments first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
Ceera Investments's AbbVie position peaked at $2.17M in Q3 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ceera Investments's 13F filing for Q2 2026, filed 6 Aug 2026.